Henry Pelish
Fortune : 7 M $ au 31/05/2026
Fortune : 7 M $ au 31/05/2026
Henry Pelish currently works at Nuvalent, Inc., as Chief Scientific Officer from 2024.
Dr. Pelish also formerly worked at Harvard University, as Research Associate.
Dr. Pelish received his doctorate degree from Harvard University, graduate degree from Stanford University, and undergraduate degree from The Johns Hopkins University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/04/2026 | 65 604 ( 0,1% ) | 7 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | Directeur Technique/Scientifique/R&D | 11/07/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national